Home/Regentis Biomaterials/Doron Besser

DB

Doron Besser

Chairman of the Board

Regentis Biomaterials

Therapeutic Areas

Orthopedics Musculoskeletal

Regentis Biomaterials Pipeline

Drug	Indication	Phase
GelrinC	Focal cartilage defects of the knee	Pivotal (US) / Marketed (EU)
GelrinB	Bone voids and defects	Clinical
GelrinSyno	Osteoarthritis	Preclinical

Leadership Team at Regentis Biomaterials

Chief Executive Officer

Prof. Dror Seliktar

Scientific Founder

View full Regentis Biomaterials profile